Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-361 | HER2amp | Luminal | Methylglyoxal | 432 | uM | 13516.184 | 0.9578 | 0.8527 | 0.5643 | |||
| MDA-MB-453 | TNBC | Luminal | Methylglyoxal | 3.46 | uM | 13647.184 | 0.9983 | 0.9973 | 1.2942 | |||
| MDA-MB-361 | HER2amp | Luminal | Methylglyoxal | 17.3 | uM | 13516.184 | 0.9687 | 0.8903 | 0.5643 | |||
| MDA-MB-361 | HER2amp | Luminal | Methylglyoxal | 10800 | uM | 13516.184 | 0.2082 | -0.8760 | 0.5643 | |||
| MDA-MB-453 | TNBC | Luminal | Methylglyoxal | 0.691 | uM | 13647.184 | 1.0066 | 1.0102 | 1.2942 | |||
| MDA-MB-453 | TNBC | Luminal | Methylglyoxal | 0.138 | uM | 13647.184 | 1.0212 | 1.0326 | 1.2942 | |||
| MDA-MB-361 | HER2amp | Luminal | Methylglyoxal | 54000 | uM | 13516.184 | 0.0068 | -0.9997 | 0.5643 |